ETOILES CAPITAL GROUP CO., LTD EFTY
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.01
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $3.2M | $2.5M | $63.9K | — |
| SG&A | $2.0M | $859.9K | $15.7K | — |
| Total operating expenses | $3.3M | $1.5M | $28.4K | — |
| Operating income | -$31.9K | $1.0M | $35.4K | — |
| Interest expense | $50.5K | $3.8K | — | — |
| Pre-tax income | -$59.5K | $996.9K | $35.4K | — |
| Income tax | $94.1K | $144.4K | $2.7K | — |
| Net income | -$153.7K | $852.5K | $32.7K | — |
| EPS, basic | -0.01 | 0.05 | 0.00 | — |
| EPS, diluted | -0.01 | 0.05 | 0.00 | — |
| Shares, diluted (wtd. avg.) | 19.1M | 18.5M | 18.5M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | $5.4M | $1.4M | $70.5K | $6.5K |
| Receivables | $239.0K | $7.2K | — | — |
| Total current assets | $6.0M | $1.8M | — | — |
| Property, plant and equipment | $658.6K | $41.9K | — | — |
| Total assets | $8.8M | $2.1M | — | — |
| Total current liabilities | $1.4M | $1.2M | — | — |
| Total liabilities | $3.0M | $1.2M | — | — |
| Retained earnings | $728.1K | $881.7K | — | — |
| Total equity | $5.8M | $888.2K | $31.6K | -$1.1K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating cash flow | -$910.7K | $1.6M | $63.9K | — |
| Depreciation and amortisation | $139.5K | $75.1K | — | — |
| Capital expenditure | $687.1K | $75.2K | — | — |
| Investing cash flow | -$687.1K | -$75.2K | — | — |
| Financing cash flow | $5.6M | -$181.7K | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-056086.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | $63.9K | $2.5M | $3.2M |
| Gross profit | — | — | — | — |
| Net income | — | $32.7K | $852.5K | -$153.7K |
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |